Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 6,080,000 shares, an increase of 28.5% from the April 15th total of 4,730,000 shares. Approximately 20.6% of the shares of the stock are short […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating)’s share price gapped up before the market opened on Friday . The stock had previously closed at $32.10, but opened at $33.40. Biomea Fusion shares last traded at $33.23, with a volume of 20,780 shares. Wall Street Analysts Forecast Growth BMEA has been the subject of a number […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) major shareholder A2a Pharmaceuticals, Inc. sold 100,000 shares of Biomea Fusion stock in a transaction on Monday, May 8th. The shares were sold at an average price of $33.99, for a total transaction of $3,399,000.00. Following the completion of the transaction, the insider now owns 3,800,000 shares in […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) traded up 6% during trading on Monday . The company traded as high as $34.96 and last traded at $34.46. 258,080 shares traded hands during mid-day trading, a decline of 60% from the average session volume of 649,297 shares. The stock had previously closed at $32.52. Wall Street […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) shares traded up 5.3% during mid-day trading on Monday . The stock traded as high as $31.32 and last traded at $31.02. 181,852 shares were traded during mid-day trading, a decline of 72% from the average session volume of 654,834 shares. The stock had previously closed at $29.47. […]